Shanghai Haohai’s Q3 Report and Governance Enhancements
Company Announcements

Shanghai Haohai’s Q3 Report and Governance Enhancements

Shanghai Haohai Biological Technology Co., Ltd. Class H (HK:6826) has released an update.

Shanghai Haohai Biological Technology Co., Ltd. has released its unaudited third-quarter financial report for 2024 and announced strategic amendments to enhance corporate governance. The company has restructured its committees by shifting ESG responsibilities to a newly renamed Strategy and Sustainable Development Committee, aiming to bolster its sustainability efforts.

For further insights into HK:6826 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App